PBAC Public Summary Documents - December 2019

Page last updated: 30 June 2020

Public Summary Documents relating to the December 2019 PBAC meeting.

• Age restrictions on inhaled corticosteroid (ICS) + long-acting beta2 agonist (LABA) fixed dose combination (FDC) products Correspondence from Clinician

• November 2019 MSAC outcomes of relevance to PBAC

• TGA Prescription Opioid Regulatory Reforms

The following Public Summary Document has been updated.

December 2019 PBAC meeting

• Age restrictions on inhaled corticosteroid (ICS) + long-acting beta2 agonist (LABA) fixed dose combination (FDC) products Correspondence from Clinician